Head and neck cancer is a major health problem worldwide, with most cases arising in the
oral cavity. Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer …

Oral lichen planus (OLP) is a common chronic inflammatory disease of unknown etiology
and likely autoimmune nature that is currently considered an oral potentially malignant …

The CD133 cell membrane glycoprotein, also termed prominin-1, is expressed on some of
the tumor cells of both solid and blood malignancies. The CD133-positive tumor cells were …

Growing evidence suggests that genetic and epigenetic factors, including environmental
factors, contribute to the development of oral squamous cell carcinoma (OSCC). Here, we …

This study reviews the molecular landscape of oral potentially malignant disorders (OPMD).
We examine the impact of tumour heterogeneity, the spectrum of driver mutations (TP53 …

Aim: To design and fabricate a multifunctional drug-delivery nanoplatform for oral cancer
therapy. Materials & methods: Polyethylene glycol-stabilized, PDPN antibody (PDPN Ab) …

Abstract Objectives Ribonucleotide reductase M2 (RRM2) is a rate‐limiting enzyme involved
in DNA repair and synthesis. This study aimed to investigate the expression level …

Our aim was to evaluate the expression of biomarkers, CD44v6, CD147, EGFR, p53, p63,
p73, p16, and podoplanin in oral leukoplakias (OL) and to assess their potential for …

Objectives Cancer stem cells (CSCs) are responsible for initiating the process of
carcinogenesis de novo, as well as through the transformation of oral potential malignant …

Introduction Despite improved therapeutics in oral squamous cell carcinoma (OSCC), tumor
cells that are either quiescent and/or endowed with stem cell–like attributes usually survive …